BELACABNAGENE FRANLEUCEL EXPRESSED MEMBRANE BOUND FORM OF IL-15 (MBIL15)
UNII ALS73C9LTW

Substance Identification & Data

This profile provides standardized clinical and technical data for Belacabnagene Franleucel Expressed Membrane Bound Form Of Il-15 (mbil15), uniquely identified by the FDA Unique Ingredient Identifier (UNII) ALS73C9LTW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ALS73C9LTW
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BELACABNAGENE FRANLEUCEL EXPRESSED MEMBRANE BOUND FORM OF IL-15 (MBIL15)
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Belacabnagene Franleucel Expressed Membrane Bound Form Of Il-15 (mbil15). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BELACABNAGENE FRANLEUCEL EXPRESSED MEMBRANE BOUND FORM OF IL-15 (MBIL15)

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record